- Home
- BLAC vs OMIC Comparison
BLAC vs OMIC Comparison
Compare BLAC & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLAC
- OMIC
- Stock Information
- Founded
- BLAC 2020
- OMIC 2016
- Country
- BLAC United States
- OMIC United States
- Employees
- BLAC N/A
- OMIC N/A
- Industry
- BLAC
- OMIC Medical/Dental Instruments
- Sector
- BLAC
- OMIC Health Care
- Exchange
- BLAC NYSE
- OMIC Nasdaq
- Market Cap
- BLAC 46.9M
- OMIC 49.9M
- IPO Year
- BLAC 2023
- OMIC 2021
- Fundamental
- Price
- BLAC $11.66
- OMIC $19.88
- Analyst Decision
- BLAC
- OMIC Hold
- Analyst Count
- BLAC 0
- OMIC 2
- Target Price
- BLAC N/A
- OMIC $10.75
- AVG Volume (30 Days)
- BLAC 4.0K
- OMIC 12.4K
- Earning Date
- BLAC 01-01-0001
- OMIC 03-17-2025
- Dividend Yield
- BLAC N/A
- OMIC N/A
- EPS Growth
- BLAC N/A
- OMIC N/A
- EPS
- BLAC N/A
- OMIC N/A
- Revenue
- BLAC N/A
- OMIC $2,667,000.00
- Revenue This Year
- BLAC N/A
- OMIC $0.82
- Revenue Next Year
- BLAC N/A
- OMIC $252.64
- P/E Ratio
- BLAC N/A
- OMIC N/A
- Revenue Growth
- BLAC N/A
- OMIC 2.77
- 52 Week Low
- BLAC $10.56
- OMIC $5.34
- 52 Week High
- BLAC $13.40
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- BLAC 57.71
- OMIC 52.36
- Support Level
- BLAC $11.22
- OMIC $19.69
- Resistance Level
- BLAC $12.54
- OMIC $19.90
- Average True Range (ATR)
- BLAC 0.24
- OMIC 0.21
- MACD
- BLAC 0.02
- OMIC 0.04
- Stochastic Oscillator
- BLAC 33.33
- OMIC 96.00
About BLAC BELLEVUE LIFE SCIENCES ACQ CORP
Bellevue Life Sciences Acquisition Corp is a blank check company.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.